Compare ADIL & SNES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ADIL | SNES |
|---|---|---|
| Founded | 2010 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Agricultural Chemicals |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.3M | 7.2M |
| IPO Year | 2017 | 2016 |
| Metric | ADIL | SNES |
|---|---|---|
| Price | $4.99 | $1.21 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $37.50 | N/A |
| AVG Volume (30 Days) | 61.8K | ★ 98.6K |
| Earning Date | 05-13-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 77.99 |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $600,000.00 |
| Revenue This Year | N/A | $29.00 |
| Revenue Next Year | N/A | $95.04 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 132.56 |
| 52 Week Low | $0.13 | $1.15 |
| 52 Week High | $5.17 | $5.15 |
| Indicator | ADIL | SNES |
|---|---|---|
| Relative Strength Index (RSI) | 65.51 | 40.84 |
| Support Level | $2.38 | $1.15 |
| Resistance Level | $5.08 | $1.81 |
| Average True Range (ATR) | 0.50 | 0.12 |
| MACD | 0.04 | -0.01 |
| Stochastic Oscillator | 75.79 | 14.16 |
Adial Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on the development of therapeutics for the treatment or prevention of addiction and related disorders. Its investigational new drug candidate, AD04, is being developed as a therapeutic agent for the treatment of alcohol use disorder. The company operates as one operating segment with a focus on drug development for addiction and related disorders.
SenesTech Inc is a United States-based biotech platform and research company engaged in developing technology for managing animal pest populations through fertility control. The company has developed and are commercializing products for managing animal pest populations through fertility control and population management strategies. Its current products focus on rat and mouse populations, and are known as: ContraPest, Evolve Rat, and Evolve Mouse.